1 Market Overview

1.1 Influenza Medication Introduction

1.2 Market Analysis by Type

1.2.1 Overview: Global Influenza Medication Revenue by Type: 2019 Versus 2021 Versus 2026

1.2.2 Zanamivir

1.2.3 Oseltamivir

1.2.4 Peramivir

1.2.5 Amantadine

1.2.6 Rimantadine

1.2.7 Inosine

1.2.8 Others

1.3 Market Analysis by Application

1.3.1 Overview: Global Influenza Medication Revenue by Application: 2019 Versus 2021 Versus 2026

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Pharmacies

1.3.5 Others

1.4 Global Influenza Medication Market Size & Forecast

1.4.1 Global Influenza Medication Sales in Value (2016-2026))

1.4.2 Global Influenza Medication Sales in Volume (2016-2026)

1.4.3 Global Influenza Medication Price by Type (2016-2026) & (USD/Unit)

1.5 Global Influenza Medication Production Capacity Analysis

1.5.1 Global Influenza Medication Total Production Capacity (2016-2026)

1.5.2 Global Influenza Medication Production Capacity by Geographic Region

1.6 Market Drivers, Restraints and Trends

1.6.1 Influenza Medication Market Drivers

1.6.2 Influenza Medication Market Restraints

1.6.3 Influenza Medication Trends Analysis

2 Manufacturers Profiles

2.1 Daiichi Sankyo Company

2.1.1 Daiichi Sankyo Company Details

2.1.2 Daiichi Sankyo Company Major Business

2.1.3 Daiichi Sankyo Company Influenza Medication Product and Services

2.1.4 Daiichi Sankyo Company Influenza Medication Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.2 GlaxoSmithKline

2.2.1 GlaxoSmithKline Details

2.2.2 GlaxoSmithKline Major Business

2.2.3 GlaxoSmithKline Influenza Medication Product and Services

2.2.4 GlaxoSmithKline Influenza Medication Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.3 Natco Pharma

2.3.1 Natco Pharma Details

2.3.2 Natco Pharma Major Business

2.3.3 Natco Pharma Influenza Medication Product and Services

2.3.4 Natco Pharma Influenza Medication Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.4 F. Hoffmann-La Roche

2.4.1 F. Hoffmann-La Roche Details

2.4.2 F. Hoffmann-La Roche Major Business

2.4.3 F. Hoffmann-La Roche Influenza Medication Product and Services

2.4.4 F. Hoffmann-La Roche Influenza Medication Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.5 Teva Pharmaceutical

2.5.1 Teva Pharmaceutical Details

2.5.2 Teva Pharmaceutical Major Business

2.5.3 Teva Pharmaceutical Influenza Medication Product and Services

2.5.4 Teva Pharmaceutical Influenza Medication Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.6 Sandoz International

2.6.1 Sandoz International Details

2.6.2 Sandoz International Major Business

2.6.3 Sandoz International Influenza Medication Product and Services

2.6.4 Sandoz International Influenza Medication Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.7 Sun Pharmaceutical Industries

2.7.1 Sun Pharmaceutical Industries Details

2.7.2 Sun Pharmaceutical Industries Major Business

2.7.3 Sun Pharmaceutical Industries Influenza Medication Product and Services

2.7.4 Sun Pharmaceutical Industries Influenza Medication Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.8 Mylan

2.8.1 Mylan Details

2.8.2 Mylan Major Business

2.8.3 Mylan Influenza Medication Product and Services

2.8.4 Mylan Influenza Medication Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

3 Influenza Medication Sales by Manufacturer

3.1 Global Influenza Medication Sales in Volume by Manufacturer (2019-2021e)

3.2 Global Influenza Medication Revenue by Manufacturer (2019-2021e)

3.3 Key Manufacturer Market Position in Influenza Medication

3.4 Market Concentration Rate

3.4.1 Top 3 Influenza Medication Manufacturer Market Share

3.4.2 Top 6 Influenza Medication Manufacturer Market Share

3.5 Global Influenza Medication Production Capacity by Company

3.6 Manufacturer by Geography: Head Office and Influenza Medication Production Site

3.7 New Entrant and Capacity Expansion Plans

3.8 Mergers & Acquisitions

4 Market Analysis by Region

4.1 Global Influenza Medication Market Size by Region

4.1.1 Global Influenza Medication Sales in Volume by Region (2016-2026)

4.1.2 Global Influenza Medication Revenue by Region (2016-2026)

4.2 North America Influenza Medication Revenue (2016-2026)

4.3 Europe Influenza Medication Revenue (2016-2026)

4.4 Asia-Pacific Influenza Medication Revenue (2016-2026)

4.5 South America Influenza Medication Revenue (2016-2026)

4.6 Middle East and Africa Influenza Medication Revenue (2016-2026)

5 Market Segment by Type

5.1 Global Influenza Medication Sales in Volume by Type (2016-2026)

5.2 Global Influenza Medication Revenue by Type (2016-2026)

5.3 Global Influenza Medication Price by Type (2016-2026)

6 Market Segment by Application

6.1 Global Influenza Medication Sales in Volume by Application (2016-2026)

6.2 Global Influenza Medication Revenue by Application (2016-2026)

6.3 Global Influenza Medication Price by Application (2016-2026)

7 North America by Country, by Type, and by Application

7.1 North America Influenza Medication Sales by Type (2016-2026)

7.2 North America Influenza Medication Sales by Application (2016-2026)

7.3 North America Influenza Medication Market Size by Country

7.3.1 North America Influenza Medication Sales in Volume by Country (2016-2026)

7.3.2 North America Influenza Medication Revenue by Country (2016-2026)

7.3.3 United States Market Size and Forecast (2016-2026)

7.3.4 Canada Market Size and Forecast (2016-2026)

7.3.5 Mexico Market Size and Forecast (2016-2026)

8 Europe by Country, by Type, and by Application

8.1 Europe Influenza Medication Sales by Type (2016-2026)

8.2 Europe Influenza Medication Sales by Application (2016-2026)

8.3 Europe Influenza Medication Market Size by Country

8.3.1 Europe Influenza Medication Sales in Volume by Country (2016-2026)

8.3.2 Europe Influenza Medication Revenue by Country (2016-2026)

8.3.3 Germany Market Size and Forecast (2016-2026)

8.3.4 France Market Size and Forecast (2016-2026)

8.3.5 United Kingdom Market Size and Forecast (2016-2026)

8.3.6 Russia Market Size and Forecast (2016-2026)

8.3.7 Italy Market Size and Forecast (2016-2026)

9 Asia-Pacific by Country, by Type, and by Application

9.1 Asia-Pacific Influenza Medication Sales by Type (2016-2026)

9.2 Asia-Pacific Influenza Medication Sales by Application (2016-2026)

9.3 Asia-Pacific Influenza Medication Market Size by Region

9.3.1 Asia-Pacific Influenza Medication Sales in Volume by Region (2016-2026)

9.3.2 Asia-Pacific Influenza Medication Revenue by Region (2016-2026)

9.3.3 China Market Size and Forecast (2016-2026)

9.3.4 Japan Market Size and Forecast (2016-2026)

9.3.5 Korea Market Size and Forecast (2016-2026)

9.3.6 India Market Size and Forecast (2016-2026)

9.3.7 Southeast Asia Market Size and Forecast (2016-2026)

9.3.8 Australia Market Size and Forecast (2016-2026)

10 South America by Country, by Type, and by Application

10.1 South America Influenza Medication Sales by Type (2016-2026)

10.2 South America Influenza Medication Sales by Application (2016-2026)

10.3 South America Influenza Medication Market Size by Country

10.3.1 South America Influenza Medication Sales in Volume by Country (2016-2026)

10.3.2 South America Influenza Medication Revenue by Country (2016-2026)

10.3.3 Brazil Market Size and Forecast (2016-2026)

10.3.4 Argentina Market Size and Forecast (2016-2026)

11 Middle East & Africa by Country, by Type, and by Application

11.1 Middle East & Africa Influenza Medication Sales by Type (2016-2026)

11.2 Middle East & Africa Influenza Medication Sales by Application (2016-2026)

11.3 Middle East & Africa Influenza Medication Market Size by Country

11.3.1 Middle East & Africa Influenza Medication Sales in Volume by Country (2016-2026)

11.3.2 Middle East & Africa Influenza Medication Revenue by Country (2016-2026)

11.3.3 Turkey Market Size and Forecast (2016-2026)

11.3.4 Egypt Market Size and Forecast (2016-2026)

11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)

11.3.6 South Africa Market Size and Forecast (2016-2026)

12 Sales Channel, Distributors, Traders and Dealers

12.1 Sales Channel

12.1.1 Direct Marketing

12.1.2 Indirect Marketing

12.2 Influenza Medication Typical Distributors

12.3 Influenza Medication Typical Customers

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Research Process and Data Source

14.3 Disclaimer

List of Tables

Table 1. Global Influenza Medication Revenue by Type, (USD Million), 2021-2026

Table 2. Global Influenza Medication Revenue by Application, (USD Million), 2021-2026

Table 3. Daiichi Sankyo Company Basic Information, Manufacturing Base and Competitors

Table 4. Daiichi Sankyo Company Major Business

Table 5. Daiichi Sankyo Company Influenza Medication Product and Services

Table 6. Daiichi Sankyo Company Influenza Medication Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 7. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors

Table 8. GlaxoSmithKline Major Business

Table 9. GlaxoSmithKline Influenza Medication Product and Services

Table 10. GlaxoSmithKline Influenza Medication Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 11. Natco Pharma Basic Information, Manufacturing Base and Competitors

Table 12. Natco Pharma Major Business

Table 13. Natco Pharma Influenza Medication Product and Services

Table 14. Natco Pharma Influenza Medication Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 15. F. Hoffmann-La Roche Basic Information, Manufacturing Base and Competitors

Table 16. F. Hoffmann-La Roche Major Business

Table 17. F. Hoffmann-La Roche Influenza Medication Product and Services

Table 18. F. Hoffmann-La Roche Influenza Medication Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 19. Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors

Table 20. Teva Pharmaceutical Major Business

Table 21. Teva Pharmaceutical Influenza Medication Product and Services

Table 22. Teva Pharmaceutical Influenza Medication Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 23. Sandoz International Basic Information, Manufacturing Base and Competitors

Table 24. Sandoz International Major Business

Table 25. Sandoz International Influenza Medication Product and Services

Table 26. Sandoz International Influenza Medication Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 27. Sun Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors

Table 28. Sun Pharmaceutical Industries Major Business

Table 29. Sun Pharmaceutical Industries Influenza Medication Product and Services

Table 30. Sun Pharmaceutical Industries Influenza Medication Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 31. Mylan Basic Information, Manufacturing Base and Competitors

Table 32. Mylan Major Business

Table 33. Mylan Influenza Medication Product and Services

Table 34. Mylan Influenza Medication Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 35. Global Influenza Medication Sales by Manufacturer (2019-2021e) & (K Units)

Table 36. Global Influenza Medication Revenue by Manufacturer (2019-2021e) & (USD Million)

Table 37. Market Position of Manufacturers in Influenza Medication, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020

Table 38. Global Influenza Medication Production Capacity by Company, (K Units): 2020 VS 2021

Table 39. Head Office and Influenza Medication Production Site of Key Manufacturer

Table 40. Influenza Medication New Entrant and Capacity Expansion Plans

Table 41. Influenza Medication Mergers & Acquisitions in the Past Five Years

Table 42. Global Influenza Medication Sales by Region (2016-2021e) & (K Units)

Table 43. Global Influenza Medication Sales by Region (2021-2026) & (K Units)

Table 44. Global Influenza Medication Revenue by Region (2016-2021e) & (USD Million)

Table 45. Global Influenza Medication Revenue by Region (2021-2026) & (USD Million)

Table 46. Global Influenza Medication Sales by Type (2016-2021e) & (K Units)

Table 47. Global Influenza Medication Sales by Type (2021-2026) & (K Units)

Table 48. Global Influenza Medication Revenue by Type (2016-2021e) & (USD Million)

Table 49. Global Influenza Medication Revenue by Type (2021-2026) & (USD Million)

Table 50. Global Influenza Medication Price by Type (2016-2021e) & (USD/Unit)

Table 51. Global Influenza Medication Price by Type (2021-2026) & (USD/Unit)

Table 52. Global Influenza Medication Sales by Application (2016-2021e) & (K Units)

Table 53. Global Influenza Medication Sales by Application (2021-2026) & (K Units)

Table 54. Global Influenza Medication Revenue by Application (2016-2021e) & (USD Million)

Table 55. Global Influenza Medication Revenue by Application (2021-2026) & (USD Million)

Table 56. Global Influenza Medication Price by Application (2016-2021e) & (USD/Unit)

Table 57. Global Influenza Medication Price by Application (2021-2026) & (USD/Unit)

Table 58. North America Influenza Medication Sales by Country (2016-2021e) & (K Units)

Table 59. North America Influenza Medication Sales by Country (2021-2026) & (K Units)

Table 60. North America Influenza Medication Revenue by Country (2016-2021e) & (USD Million)

Table 61. North America Influenza Medication Revenue by Country (2021-2026) & (USD Million)

Table 62. North America Influenza Medication Sales by Type (2016-2021e) & (K Units)

Table 63. North America Influenza Medication Sales by Type (2021-2026) & (K Units)

Table 64. North America Influenza Medication Sales by Application (2016-2021e) & (K Units)

Table 65. North America Influenza Medication Sales by Application (2021-2026) & (K Units)

Table 66. Europe Influenza Medication Sales by Country (2016-2021e) & (K Units)

Table 67. Europe Influenza Medication Sales by Country (2021-2026) & (K Units)

Table 68. Europe Influenza Medication Revenue by Country (2016-2021e) & (USD Million)

Table 69. Europe Influenza Medication Revenue by Country (2021-2026) & (USD Million)

Table 70. Europe Influenza Medication Sales by Type (2016-2021e) & (K Units)

Table 71. Europe Influenza Medication Sales by Type (2021-2026) & (K Units)

Table 72. Europe Influenza Medication Sales by Application (2016-2021e) & (K Units)

Table 73. Europe Influenza Medication Sales by Application (2021-2026) & (K Units)

Table 74. Asia-Pacific Influenza Medication Sales by Region (2016-2021e) & (K Units)

Table 75. Asia-Pacific Influenza Medication Sales by Region (2021-2026) & (K Units)

Table 76. Asia-Pacific Influenza Medication Revenue by Region (2016-2021e) & (USD Million)

Table 77. Asia-Pacific Influenza Medication Revenue by Region (2021-2026) & (USD Million)

Table 78. Asia-Pacific Influenza Medication Sales by Type (2016-2021e) & (K Units)

Table 79. Asia-Pacific Influenza Medication Sales by Type (2021-2026) & (K Units)

Table 80. Asia-Pacific Influenza Medication Sales by Application (2016-2021e) & (K Units)

Table 81. Asia-Pacific Influenza Medication Sales by Application (2021-2026) & (K Units)

Table 82. South America Influenza Medication Sales by Country (2016-2021e) & (K Units)

Table 83. South America Influenza Medication Sales by Country (2021-2026) & (K Units)

Table 84. South America Influenza Medication Revenue by Country (2016-2021e) & (USD Million)

Table 85. South America Influenza Medication Revenue by Country (2021-2026) & (USD Million)

Table 86. South America Influenza Medication Sales by Type (2016-2021e) & (K Units)

Table 87. South America Influenza Medication Sales by Type (2021-2026) & (K Units)

Table 88. South America Influenza Medication Sales by Application (2016-2021e) & (K Units)

Table 89. South America Influenza Medication Sales by Application (2021-2026) & (K Units)

Table 90. Middle East & Africa Influenza Medication Sales by Country (2016-2021e) & (K Units)

Table 91. Middle East & Africa Influenza Medication Sales by Country (2021-2026) & (K Units)

Table 92. Middle East & Africa Influenza Medication Revenue by Country (2016-2021e) & (USD Million)

Table 93. Middle East & Africa Influenza Medication Revenue by Country (2021-2026) & (USD Million)

Table 94. Middle East & Africa Influenza Medication Sales by Type (2016-2021e) & (K Units)

Table 95. Middle East & Africa Influenza Medication Sales by Type (2021-2026) & (K Units)

Table 96. Middle East & Africa Influenza Medication Sales by Application (2016-2021e) & (K Units)

Table 97. Middle East & Africa Influenza Medication Sales by Application (2021-2026) & (K Units)

Table 98. Direct Channel Pros & Cons

Table 99. Indirect Channel Pros & Cons

Table 100. Influenza Medication Typical Distributors

Table 101. Influenza Medication Typical Customers

List of Figures

Figure 1. Influenza Medication Picture

Figure 2. Global Influenza Medication Sales Market Share by Type in 2020

Figure 3. Zanamivir

Figure 4. Oseltamivir

Figure 5. Peramivir

Figure 6. Amantadine

Figure 7. Rimantadine

Figure 8. Inosine

Figure 9. Others

Figure 10. Global Influenza Medication Sales Market Share by Application in 2020

Figure 11. Hospitals

Figure 12. Clinics

Figure 13. Pharmacies

Figure 14. Others

Figure 15. Global Influenza Medication Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026

Figure 16. Global Influenza Medication Market Size and Forecast (2016-2026) & (USD Million)

Figure 17. Global Influenza Medication Sales (2016-2026) & (K Units)

Figure 18. Global Influenza Medication Price by Type (2016-2026) & (USD/Unit)

Figure 19. Global Influenza Medication Production Capacity (2016-2026) & (K Units)

Figure 20. Global Influenza Medication Production Capacity by Geographic Region: 2020 VS 2021

Figure 21. Influenza Medication Market Drivers

Figure 22. Influenza Medication Market Restraints

Figure 23. Influenza Medication Market Trends

Figure 24. Global Influenza Medication Sales Market Share by Manufacturer in 2020

Figure 25. Global Influenza Medication Revenue Market Share by Manufacturer in 2020

Figure 26. Influenza Medication Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 27. Top 3 Influenza Medication Manufacturer (Revenue) Market Share in 2020

Figure 28. Top 6 Influenza Medication Manufacturer (Revenue) Market Share in 2020

Figure 29. Global Influenza Medication Sales Market Share by Region (2016-2026)

Figure 30. Global Influenza Medication Revenue Market Share by Region (2016-2026)

Figure 31. North America Influenza Medication Revenue (2016-2026) & (USD Million)

Figure 32. Europe Influenza Medication Revenue (2016-2026) & (USD Million)

Figure 33. Asia-Pacific Influenza Medication Revenue (2016-2026) & (USD Million)

Figure 34. South America Influenza Medication Revenue (2016-2026) & (USD Million)

Figure 35. Middle East & Africa Influenza Medication Revenue (2016-2026) & (USD Million)

Figure 36. Global Influenza Medication Sales Market Share by Type (2016-2026)

Figure 37. Global Influenza Medication Revenue Market Share by Type (2016-2026)

Figure 38. Global Influenza Medication Price by Type (2016-2026) & (USD/Unit)

Figure 39. Global Influenza Medication Sales Market Share by Application (2016-2026)

Figure 40. Global Influenza Medication Revenue Market Share by Application (2016-2026)

Figure 41. Global Influenza Medication Price by Application (2016-2026) & (USD/Unit)

Figure 42. North America Influenza Medication Sales Market Share by Type (2016-2026)

Figure 43. North America Influenza Medication Sales Market Share by Application (2016-2026)

Figure 44. North America Influenza Medication Sales Market Share by Country (2016-2026)

Figure 45. North America Influenza Medication Revenue Market Share by Country (2016-2026)

Figure 46. United States Influenza Medication Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 47. Canada Influenza Medication Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 48. Mexico Influenza Medication Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 49. Europe Influenza Medication Sales Market Share by Type (2016-2026)

Figure 50. Europe Influenza Medication Sales Market Share by Application (2016-2026)

Figure 51. Europe Influenza Medication Sales Market Share by Country (2016-2026)

Figure 52. Europe Influenza Medication Revenue Market Share by Country (2016-2026)

Figure 53. Germany Influenza Medication Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 54. France Influenza Medication Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 55. United Kingdom Influenza Medication Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 56. Russia Influenza Medication Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 57. Italy Influenza Medication Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 58. Asia-Pacific Influenza Medication Sales Market Share by Region (2016-2026)

Figure 59. Asia-Pacific Influenza Medication Sales Market Share by Application (2016-2026)

Figure 60. Asia-Pacific Influenza Medication Sales Market Share by Region (2016-2026)

Figure 61. Asia-Pacific Influenza Medication Revenue Market Share by Region (2016-2026)

Figure 62. China Influenza Medication Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 63. Japan Influenza Medication Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 64. Korea Influenza Medication Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 65. India Influenza Medication Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 66. Southeast Asia Influenza Medication Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 67. Australia Influenza Medication Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 68. South America Influenza Medication Sales Market Share by Type (2016-2026)

Figure 69. South America Influenza Medication Sales Market Share by Application (2016-2026)

Figure 70. South America Influenza Medication Sales Market Share by Country (2016-2026)

Figure 71. South America Influenza Medication Revenue Market Share by Country (2016-2026)

Figure 72. Brazil Influenza Medication Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 73. Argentina Influenza Medication Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 74. Middle East & Africa Influenza Medication Sales Market Share by Type (2016-2026)

Figure 75. Middle East & Africa Influenza Medication Sales Market Share by Application (2016-2026)

Figure 76. Middle East & Africa Influenza Medication Sales Market Share by Country (2016-2026)

Figure 77. Middle East & Africa Influenza Medication Revenue Market Share by Country (2016-2026)

Figure 78. Turkey Influenza Medication Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 79. Egypt Influenza Medication Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 80. Saudi Arabia Influenza Medication Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 81. South Africa Influenza Medication Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 82. Sales Channel: Direct Channel vs Indirect Channel

Figure 83. Methodology

Figure 84. Research Process and Data Source